Abstract
Many studies have shown that pyrazoline derivatives have therapeutic potential as antidepressant drugs. In this study, we aimed to investigate the antidepressant-like effect of eight new 1-[(N,N-disubstituted thiocarbamoylthio)acetyl]-3-(2-thienyl)-5-aryl-2-pyrazolines that have previously been synthesized in our laboratory. Antidepressant-like activity was investigated in mouse forced swimming test (FST). Drug-induced effects on motor function were also tested by using digitized motor activity monitoring system. Shortened immobility time in FST was accepted as indicator of antidepressant-like activity. Results showed that three of eight pyrazoline compounds (1b, 1d, 1g) significantly shortened immobility time compared with control. Compound 1b was found to be more effective in FST than were clomipramine and tranylcypromine, used as reference antidepressant drugs. This compound also significantly increased horizontal motor activity, like clomipramine, compared with control mice. These results suggest that the N,N-disubstituted dithiocarbamate moiety of pyrazoline derivatives may have therapeutic antidepressant potential.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bilgin AA, Palaska E, Sunal R (1993) Studies on the synthesis and antidepressant activity of some 1-thiocarbamoyl-3,5-diphenyl-2-pyrazolines. Arzneim-Forsch. Drug Res 43:1041–1044
Ferigolo M, Barros HM, Marquardt AR, Tannhauser M (1998) Comparison of behavioral effects of moclobemide and deprenyl during forced swimming. Pharmacol Biochem Behav 60:431–437. doi:10.1016/S0091-3057(98)00011-2
Gökhan N, Yeşilada A, Uçar G, Erol K, Bilgin AA (2003) 1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines:synthesis and evaluation as MAO inhibitors. Arch Pharm Pharm Med Chem 336:362–371. doi:10.1002/ardp.200300732
Maj J, Rogóz Z, Skuza G, Sowińska H (1992) The effect of antidepressant drugs on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist. Neuropharmacol 31:685–691
Özdemir A, Turan-Zitouni G, Kaplancıklı ZA (2008) Novel analogues of 2-pyrazoline: synthesis, characterization and antimycobacterial evaluation. Turk J Chem 32:529–532
Palaska E, Erol D, Demirdamar R (1996) Synthesis and antidepressant activities of some 1,3,5-triphenyl-2-pyrazolines. Eur J Med Chem 31:43–47. doi:10.1016/S0223-5234(96)80005-5
Palaska E, Aytemir M, Uzbay İT, Erol D (2001) Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines. Eur J Med Chem 36:539–543. doi:10.1016/S0223-5234(01)01243-0
Parmar SS, Pandey BR, Dwivedi C, Harbison RD (1974) Anticonvulsant activity and monoamine oxidase inhibitory properties of 1,3,5-trisubstituted pyrazolines. J Pharm Sci 63:1152–1155. doi:10.1002/jps.2600630730
Porsolt RD, Bertin A (1977) Behavioural despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327–336
Prasad YR, Rao AL, Prasoona L, Murali K, Kumar PR (2005) Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2ıı-hydroxynaphthalen-1ıı-yl)-1,5-diphenyl-2-pyrazolines. Bioorg Med Chem Lett 15:5030–5034. doi:10.1016/j.bmcl.2005.08.040
Shader RI, Greenblatt DJ (1999) The reappearance of a monamine oxidase inhibitor (isocarboxazid). J Clin Psychopharmacol 19:105–106. doi:10.1097/00004714-199904000-00001
Soni N, Pande K, Kalsi R, Gupta TK, Parmar SS, Barthwal JP (1987) Inhibition of rat brain monoamine oxidase and succinic dehydrogenase by anticonvulsant pyrazolines. Res Commun Cement Pathol Pharm 56:129–132
Turan-Zitouni G, Chevallet P, Kiliç FS, Erol K (2000) Synthesis of some thiazolyl-pyrazoline derivatives and preliminary investigation of their hypotensive activityynthesis of some thiazolylpyrazoline derivatives and preliminary investigation of their hypotensive activity. Eur J Med Chem 35:635–641
Urichuk LJ, Allison K, Holt A, Greensaw AJ, Baker GB (2000) Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration. J Affect Disord 58:135–144. doi:10.1016/S0165-0327(99)00105-6
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gok, S., Murat Demet, M., Özdemir, A. et al. Evaluation of antidepressant-like effect of 2-pyrazoline derivatives. Med Chem Res 19, 94–101 (2010). https://doi.org/10.1007/s00044-009-9176-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-009-9176-x